BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 28288630)

  • 1. Overexpression of G protein-coupled receptor GPR87 promotes pancreatic cancer aggressiveness and activates NF-κB signaling pathway.
    Wang L; Zhou W; Zhong Y; Huo Y; Fan P; Zhan S; Xiao J; Jin X; Gou S; Yin T; Wu H; Liu T
    Mol Cancer; 2017 Mar; 16(1):61. PubMed ID: 28288630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway.
    Yu C; Chen S; Guo Y; Sun C
    Theranostics; 2018; 8(12):3224-3236. PubMed ID: 29930725
    [No Abstract]   [Full Text] [Related]  

  • 3. Overexpression of PIMREG promotes breast cancer aggressiveness via constitutive activation of NF-κB signaling.
    Jiang L; Ren L; Zhang X; Chen H; Chen X; Lin C; Wang L; Hou N; Pan J; Zhou Z; Huang H; Huang D; Yang J; Liang Y; Li J
    EBioMedicine; 2019 May; 43():188-200. PubMed ID: 30979686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway.
    He S; Niu G; Shang J; Deng Y; Wan Z; Zhang C; You Z; Shen H
    J Exp Clin Cancer Res; 2017 Oct; 36(1):137. PubMed ID: 28978336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G Protein-Coupled Receptor 87 (GPR87) Promotes Cell Proliferation in Human Bladder Cancer Cells.
    Zhang X; Liu D; Hayashida Y; Okazoe H; Hashimoto T; Ueda N; Sugimoto M; Kakehi Y
    Int J Mol Sci; 2015 Oct; 16(10):24319-31. PubMed ID: 26473854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.
    Wang X; Lin C; Zhao X; Liu A; Zhu J; Li X; Song L
    Mol Cancer; 2014 May; 13():106. PubMed ID: 24886245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of TRIM14 promotes tongue squamous cell carcinoma aggressiveness by activating the NF-κB signaling pathway.
    Su X; Wang J; Chen W; Li Z; Fu X; Yang A
    Oncotarget; 2016 Mar; 7(9):9939-50. PubMed ID: 26799420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness.
    Peng T; Zhou W; Guo F; Wu HS; Wang CY; Wang L; Yang ZY
    Sci Rep; 2017 Jul; 7(1):5925. PubMed ID: 28724890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
    Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
    Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Cell-surface Molecular GPR87 With GPR87-suppressing Adenoviral Vector Disturb Tumor Proliferation in Lung Cancer Cells.
    Kita Y; Go T; Nakashima N; Liu D; Tokunaga Y; Zhang X; Nakano T; Nii K; Chang SS; Yokomise H
    Anticancer Res; 2020 Feb; 40(2):733-741. PubMed ID: 32014915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway.
    Xu X; Yu Y; Zong K; Lv P; Gu Y
    J Exp Clin Cancer Res; 2019 Dec; 38(1):497. PubMed ID: 31852504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of tongue squamous cell carcinoma (TSCC) via activation of NF-κB signaling.
    Chen WC; Li QL; Pan Q; Zhang HY; Fu XY; Yao F; Wang JN; Yang AK
    J Exp Clin Cancer Res; 2019 Apr; 38(1):167. PubMed ID: 30995931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells.
    Wang Z; Zhang Y; Banerjee S; Li Y; Sarkar FH
    Cancer; 2006 Jun; 106(11):2503-13. PubMed ID: 16628653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
    Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
    J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma.
    Gong H; Song L; Lin C; Liu A; Lin X; Wu J; Li M; Li J
    Clin Cancer Res; 2013 Mar; 19(5):1083-93. PubMed ID: 23319823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma cell aggressiveness by activating the NF-κB pathway.
    Dai T; Zhang D; Cai M; Wang C; Wu Z; Ying Z; Wu J; Li M; Xie D; Li J; Song L
    J Pathol; 2015 Feb; 235(3):490-501. PubMed ID: 25385148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of
    Jiao HL; Ye YP; Yang RW; Sun HY; Wang SY; Wang YX; Xiao ZY; He LQ; Cai JJ; Wei WT; Chen YR; Gu CC; Cai YL; Hu YT; Lai QH; Qiu JF; Liang L; Cao GW; Liao WT; Ding YQ
    Clin Cancer Res; 2017 Nov; 23(22):7108-7118. PubMed ID: 28912140
    [No Abstract]   [Full Text] [Related]  

  • 18. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
    Chen J; Ouyang ZG; Zhang SH; Zhen YS
    Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling via G proteins mediates tumorigenic effects of GPR87.
    Niss Arfelt K; Fares S; Sparre-Ulrich AH; Hjortø GM; Gasbjerg LS; Mølleskov-Jensen AS; Benned-Jensen T; Rosenkilde MM
    Cell Signal; 2017 Jan; 30():9-18. PubMed ID: 27865873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling.
    Li J; Wu H; Li W; Yin L; Guo S; Xu X; Ouyang Y; Zhao Z; Liu S; Tian Y; Tian Z; Ju J; Ni B; Wang H
    Oncogene; 2016 Oct; 35(42):5501-5514. PubMed ID: 27065335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.